Showing results (391-400 of 2,810) with videos related to

Sort By:
Pageof 281
Expert Opinion on Drug Safety|November 7, 2017
Skin cancer associated with commonly prescribed drugs: tumor necrosis factor alpha inhibitors (TNF-αIs), angiotensin-receptor blockers (ARBs), phosphodiesterase type 5 inhibitors (PDE5Is) and statins -weighing the evidenceBeatrice Nardone, Kelsey A Orrell, Paras P Vakharia, et al.
Expert Opinion on Drug Safety|January 25, 2018
Anticoagulant and antiplatelet therapy choices for patients with atrial fibrillation one year after coronary stenting or acute coronary syndromeChristoph B Olivier, Mintu P Turakhia, Kenneth W Mahaffey
Expert Opinion on Drug Safety|December 22, 2018
The quality of spontaneous adverse drug reaction reports from the pharmacovigilance centre in western ChinaRui Niu, Yufang Xiang, Tingting Wu, et al.
Expert Opinion on Drug Safety|January 15, 2019
Safety of clinical practice guideline-recommended antiemetic agents for the prevention of acute chemotherapy-induced nausea and vomiting in pediatric patients: a systematic review and meta-analysisPriya Patel, Edric Paw Cho Sing, L Lee Dupuis
Expert Opinion on Drug Safety|December 13, 2018
An update on the clinical consequences of polypharmacy in older adults: a narrative reviewJonas W Wastesson, Lucas Morin, Edwin C K Tan, et al.
Expert Opinion on Drug Safety|February 14, 2018
Improving multiple sclerosis management and collecting safety information in the real world: the MSDS3D software approachRocco Haase, Maria Wunderlich, Anja Dillenseger, et al.
Expert Opinion on Drug Safety|December 25, 2018
The safety of lanreotide for neuroendocrine tumorAmandeep Godara, Nauman S Siddiqui, Margaret M Byrne, et al.
Expert Opinion on Drug Safety|May 13, 2009
Non-investigational antiarrhythmic drugs: long-term use and limitationsKnut Gjesdal
Expert Opinion on Drug Safety|February 25, 2009
How safe is the use of thiazolidinediones in clinical practice?C V Rizos, M S Elisaf, D P Mikhailidis, et al.
Expert Opinion on Drug Safety|July 21, 2009
The safety and usefulness of low molecular weight heparins and unfractionated heparins in patients with acute strokeInes C Kiphuth, Martin Köhrmann, Hagen B Huttner, et al.
Pageof 281